Investor's Conference Speculation
Less than four (4) months ago we had our annual meeting and Harvey gave us an update on our various projects.
This was followed by an early (up to may 2012) 113 abstract released by ESMO.
This was followed by a presentation at ESMO updating the 113 data, along with a PR the same day.
We then had an analyst conference regarding what the company had just presented at ESMO on 113.
So why do you suspect that Harvey scheduled the upcoming "Investors conference (October 17)?.
What do you think he wants to tell us sharehiolders (and perhaps the world) ?.
With what has transpired these past four months (see above), I doubt that he merely wants to give us a further update, as we have already been updated.
Will Harvey be telling us (and wall street) about Ariad's new molecule and outlining the Phase 1 details? Keep in mind that Harvey has recently told us that when the next molecule is announced, the pre clinical work will be done and ready to enter into a Phase 1.
What are your thoughts about what the purpose of the Investors Conference is?
Lets hear your suggestions.
JMHO,
Barry
